NCT04838314

Brief Summary

Pediatric Liver transplantation surgery is associated with moderate to severe postoperative pain that is related to large abdominal incision cutting muscles and fascia and the anterior abdominal wall and drains. Peri-operative pain management after this surgery is centered on intravenous opioids, which cannot provide complete pain relief and are responsible for side effects such as vomiting or respiratory depression. Fifty-two per cent of pediatric patients reported moderate to severe pain on the day of surgery and 33% on day 1. 42% of patients reported vomiting. Increasing interest has focused on opioid sparing analgesic strategies to avoid some of the detrimental side effects of opioids. Recently, the focus has been on postoperative regional analgesia after major pediatric in major thoracic or abdominal surgeries. Thoracic epidural anesthesia or paravertebral blocks are efficacious but raise some concerns related to their potential complications especially in Liver transplantation with the risk of coagulation disorders. Erector spinae plane block (ESPB) is an interfascial plane block whereby Local anesthestic (LA) is injected beneath the iliocostalis, longissimus, and spinalis muscles to achieve multi metameric analgesia for pediatric thoracic, cardiac, or abdominal surgery. I Investigators' hypothesis is with efficient peri operative regional analgesia will reduce the opioids consumption, allow a very early extubation after such long surgeries and improve the quality of recovery by reducing the side effects of opioids as sedation. nausea vomiting delay of first intake.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 1, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 9, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

June 1, 2021

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 14, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 14, 2023

Completed
Last Updated

August 21, 2023

Status Verified

August 1, 2023

Enrollment Period

2.2 years

First QC Date

April 1, 2021

Last Update Submit

August 15, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • peri operative Opioids consumption

    Dose of opioids used

    up to day 7 after the end of surgery

Secondary Outcomes (5)

  • Time to extubate

    up to 6 hours after the end of the surgery

  • Duration of stay in Intensive care Unit (ICU)

    up to 72 hours after the end of the surgery

  • Length of stay in hospital

    up to 30 day after the end of the surgery

  • first intake

    up to 72hours after the end of the surgery

  • first mobilisation

    up to 72hours after the end of the surgery

Study Arms (2)

Standard of cares

NO INTERVENTION

Peri operative analgesia by opioids

regional analgesia

EXPERIMENTAL

Peri operative analgesia by continuous bilateral ESP catheters

Procedure: regional analgesia

Interventions

Peri operative regional analgesia by bilateral ESP catheter for 72h

regional analgesia

Eligibility Criteria

Age12 Months - 15 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Recipient liver transplantation who accepted to participate ( parents or guardians)

You may not qualify if:

  • Refusal participation.
  • Allergy to LA
  • Intubated ventilated pre-operation
  • Severe coagulation disorder
  • Coma
  • Prediction of large volume liver implanted
  • After surgery performed Large volume implanted with a need of post operative controlled ventilation
  • After surgery performed Organ failure
  • After surgery performed Unstable patient

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

VinMec International hospital

Hanoi, Vietnam

Location

Study Officials

  • philippe Macaire, MD

    VinMEC

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: randomized controlled prospective trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 1, 2021

First Posted

April 9, 2021

Study Start

June 1, 2021

Primary Completion

August 14, 2023

Study Completion

August 14, 2023

Last Updated

August 21, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Locations